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survival signaled by autocrine
PDGFR activity
Simon Wilkinson, Jim O’Prey, Michael Fricker,
and Kevin M. Ryan1
Tumour Cell Death Laboratory, Beatson Institute for Cancer
Research, Glasgow G61 1BD, United Kingdom
The selective regulation of macroautophagy remains
poorly defined. Here we report that PDGFR signaling is
an essential selective promoter of hypoxia-induced
macroautophagy. Hypoxia-induced macroautophagy in
tumor cells is also HIF1a-dependent, with HIF1a inte-
grating signals from PDGFRs and oxygen tension. In-
hibition of PDGFR signaling reduces HIF1a half-life,
despite buffering of steady-state protein levels by a com-
pensatory increase in HIF1a mRNA. This markedly
changes HIF1a protein pool dynamics, and consequently
reduces the HIF1a transcriptome. As autocrine growth
factor signaling is a hallmark of many cancers, cell-
autonomous enhancement of HIF1a-mediated macro-
autophagy may represent a mechanism for augmenting
tumor cell survival under hypoxic conditions.
Supplemental material is available at http://www.genesdev.org.
Received January 9, 2009; revised version accepted April 14,
2009.
During macroautophagy, autophagosomal vesicles (auto-
phagosomes) transport organelles or proteins from the
cytosol to the lysosome (Xie and Klionsky 2007). Cellular
signals promote the formation of autophagosomes and
determine which cytosolic cargoes are sequestered. Mac-
roautophagy has a homeostatic role in general clearing of
damaged organelles and proteins in most tissues
(Mizushima et al. 2004; Hara et al. 2006; Komatsu et al.
2006). However, in certain situations, cellular stresses
induce macroautophagy as an adaptive reponse for the
maintenance of cell viability. For example, mitophagy,
the specific autophagic degradation of mitochondria, can
limit apoptosis in response to cytotoxic agents (Xue et al.
2001; Colell et al. 2007) or down-regulate oxidative
phosphorylation as part of the adaptation of primary cells
to hypoxia (Zhang et al. 2008). When cells are under
conditions of metabolic stress, such as when extracellular
nutrients are low, general macroautophagy may be in-
duced to break down cellular proteins into catabolic and
anabolic precurors, relieving energy demand and assisting
cell survival (Kuma et al. 2004; Scott et al. 2004; Lum
et al. 2005; Jin et al. 2007); in the absence of macro-
autophagy, depletion of energy levels and necrosis or
apoptosis occurs (Boya et al. 2005; Jin et al. 2007).
Although macroautophagy appears to operate broadly as
a survival mechanism in cells, there is also mounting
evidence that in specific circumstances elevated macro-
autophagy may be an integral component of cell death
programs, although the mechanistic basis for the pro-
death role of macroautophagy is unknown (Shimizu et al.
2004; Yu et al. 2004; Feng et al. 2005; Crighton et al.
2006).
Results and Discussion
Tumor cells encounter hypoxic conditions and become
metabolically stressed within poorly vascularized regions
of tumors in vivo (Degenhardt et al. 2006). Indeed, macro-
autophagy colocalizes with hypoxia and promotes cell
survival in these regions of tumors (Degenhardt et al.
2006). In a human tumor cell line model, BE colorectal
carcinoma, stably expressing GFP-LC3, we found that
hypoxia induces macroautophagy, as assessed by accu-
mulation of GFP-LC3 puncta, a marker for autophago-
somes (Fig. 1A; Kabeya et al. 2000). Using siRNA
oligonucleotides targeting the macroautophagy gene
ATG5 (Crighton et al. 2006), we abrogated the autophagic
response (Fig. 1B–D) and observed both a decrease in cell
viability under hypoxic conditions (Fig. 1E) and a decrease
in long-term viability and regrowth potential when cells
were replated for outgrowth in a clonogenic survival
assay post-treatment (Fig. 1F). These data show that
hypoxia-induced macroautophagy is an adaptive mecha-
nism that maintains tumor cell viability in hypoxic
environments.
In order to identify signaling mechanisms controlling
hypoxia-induced macroautophagy in tumor cells, we
performed an RNAi screen across the protein kinome in
Drosophila S2R+ GFP-LC3 reporter cells (cell line de-
scribed in Supplemental Fig. 1A,B) in order to obtain
candidate kinase regulators. We identified the receptor
tyrosine kinase Pvr as necessary for accumulation of GFP-
LC3 puncta in response to hypoxia (Supplemental Fig.
1C). There are eight sequence orthologs of Pvr in human
cells: the VEGFR family kinases Kdr, Flt4, and Flt1, and
the PDGFR family kinases PDGFRa, PDGFRb, Flt3, FMS,
and Kit (Supplemental Fig. 2A). We next sought to de-
termine if autocrine signaling through any of these might
promote hypoxia-induced macroautophagy in tumor
cells.
We tested small-molecule inhibitors of VEGFR and
PDGFR family member kinase activity. With VEGFR
inhibitors we found no effect (data not shown), but with
an inhibitor targeting the PDGFR family (PDGFR-I), we
observed dimunition of the accumulation of GFP-LC3
puncta in BE cells in response to hypoxia (Fig. 2A). This
effect was specific to hypoxia, as the effect of glucose or
amino acid starvation in inducing accumulation of GFP-
LC3 puncta was unperturbed (Fig. 2A). The endogenous
LC3-II to LC3-I ratio, another marker of autophagosome
accumulation, was also increased by hypoxia, but was
diminished by PDGFR-I, further confirming the conclu-
sions from the puncta analysis (Fig. 2B). These experi-
ments were performed under serum-free conditions.
Nevertheless, activity of PDGFRb, the main documented
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target of PDGFR-I that is expressed in BE cells (Supple-
mental Fig. 2B), was constitutively observed in both
normoxic and hypoxic conditions and, as expected, this
was abrogated by inhibitor treatment (Fig. 2C). These
data suggested a constitutive autocrine signaling loop
through PDGFRb that is permissive for hypoxia-induced
macroautophagy. Confirming this, inhibition of PDGFRb
by siRNA transfection also reduced the number of GFP-
LC3 puncta seen under hypoxic conditions (Fig. 2D). Of
the other PDGFR family members, FMS was also detect-
able in the cells, albeit in our hands only by semiquan-
titative PCR (Supplemental Fig. 2B), not at the protein
level. Although not documented previously, we observed
that PDGFR-I could inhibit FMS kinase activity, at least
in vitro (Supplemental Fig. 2C). We therefore tested
whether FMS inhibition by RNAi also reduced autophagy
under hypoxic conditions, and found that this was the
case (Fig. 2E). PDGFR-II, a second, chemically unrelated
inhibitor of PDGFRb, and FMS (Supplemental Fig. 2C)
also decreased autophagosome levels (Supplemental Fig.
2D). RNAi against Flt1 and Kdr, the two VEGFR family
isoforms we could detect expression of in this cell line,
did not inhibit autophagy (Supplemental Fig. 2E–G).
Taken together, these data show that autocrine PDGFRb
and FMS signaling permits hypoxia-induced macroau-
tophagy in a tumor cell line. Consistent with this, we
observed that these cells secrete the PDGFRb and FMS
ligands PDGF and CSF-1 (Supplemental Fig. 2H) and
that addition of exogenous PDGF can modestly promote
hypoxia-induced autophagy (Supplemental Fig. 2I).
Further measures of hypoxia-induced autophagy in BE
cells demonstrated that, in contrast to the effect of
hypoxia-induced macroautophagy in mouse embryonic
fibroblasts (MEFs) (Zhang et al. 2008), mitochondria (as
assessed by COX-IV levels) were not targeted for degra-
Figure 1. Hypoxia-induced autophagy promotes cell viability in
tumor cells. BE GFP-LC3 cells(33105) were plated overnight in six-
well dishes and cultured for 8 h in normoxic conditions (21% O2) or
hypoxic conditions (1% O2), and then fixed for fluorescence micro-
scopic imaging of GFP-LC3 (bar, 50 mm) (A); or transfected with
siRNA oligonucleotides NTC1, NTC2, ATG5 si1, or ATG5 si2 (B–F).
Forty-eight hours later, cells were immunoblotted for indicated
proteins (B) or kept in normoxic conditions (21% O2) or exposed
to hypoxic conditions (0.5% O2) (C–F), and 24 h later were fixed for
imaging of GFP-LC3 by fluorescence microscopy (C,D) (C contains
representative images [bar, 25 mm]; D shows analysis of number of
cells containing GFP-LC3 puncta [n = 3 6 SEM; {***} P < 0.005 vs.
either NTC]) or 96 h later harvested and stained with propidium
iodide for flow cytometric analysis of dead cell number (n = 3 6
SEM; [*] P < 0.05 vs. either NTC) (E) or replated for assessment of
colony formation potential upon re-exposure to normoxic condi-
tions (n = 6 6 SD; [#] not significant; [***] P < 0.005, vs. cells not
exposed to hypoxic stress) (F). Figure 2. PDGFR family signaling promotes hypoxia-induced
autophagy of cytosolic protein. (A) BE GFP-LC3 cells at confluence
were cultured in serum-free medium (SFM) (21% O2) or EBSS (no
amino acids [no a.a.]) or glucose-free medium (no glucose), all at 21%
O2, or in SFM at 1% O2 (1% O2), plus DMSO vehicle or PDGFR-I (5
mM) for 8 h, whereupon cells were fixed and analyzed for GFP-LC3
puncta by fluorescence microscopy (n = 3 6 SEM; [*] P < 0.05; [**]
P < 0.01; [***] P < 0.005 vs. DMSO control). (B) Parental BE cells (no
GFP-LC3 transgene) were cultured in SFM under normoxia (21% O2)
or hypoxia (1% O2) plus DMSO or PDGFR-I (5 mM) for 4 h and then
lysed and immunoblotted for LC3 isoform quantification. (C) BE
GFP-LC3 cells at confluence were cultured in SFM under normoxia
(21% O2) or hypoxia (1% O2) plus DMSO or PDGFR-I (5 mM) for 4 h
and then lysed and immunoprecipitated for PDGFRb and probed for
phospho-tyrosine and PDGFRb. (D,E) BE GFP-LC3 cells were trans-
fected with indicated siRNA oligonucleotides (nontargeting control
[NTC1], or PDGFRb or FMS targeting) and at 36 h post-transfection
cultured in SFM under normoxia (21% O2) or hypoxia (1% O2)
overnight before scoring of the number of GFP-LC3 puncta-positive
cells (n = 36 SEM; [**] P < 0.01; [***] P < 0.005; [#] not significant vs.
NTC1). Silencing of targets was confirmed by immunoblotting (D,
inset) or qPCR (E) (numbers in parentheses indicate relative mRNA
levels). (F,G) BE GFP-LC3 cells at confluence were cultured in SFM
under normoxia (21% O2) or hypoxia (1% O2) plus DMSO, PDGFR-I
(5 mM) (F) or E64d (10 mg/mL) plus pepstatin A (10 mg/mL) (G) for 8 h
(F) or 24 h (G), and then lysed and immunoblotted for indicated
proteins. (H) BE GFP-LC3 cells and primary MEFs at confluence
were cultured in SFM under normoxia (21% O2) or hypoxia (1% O2)
for indicated times and lysed and immunoblotted for indicated
proteins. See Supplemental Figure 2J for quantification.
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dation, while the cytosolic macroautophagy target pro-
tein p62 was degraded. We observed specific down-regu-
lation of p62, dependent on PDGFR signaling (Fig. 2F), via
a lysosomal degradation pathway inhibitable by the pro-
tease inhibitors E64d and pepstatin A (Fig. 2G). In MEFs,
hypoxia-induced mitophagy is required to down-regulate
oxidative phosphorylation to prevent reactive oxygen
species accumulation (Zhang et al. 2008). Indeed, analysis
of longer time courses of hypoxia demonstrate amarkedly
greater down-regulation of mitochondrial antigens (COX-
IV and TOM-20) in primary MEFs as compared with BE
tumor cells (Fig. 2H; quantification in Supplemental Fig.
2J). In these tumor cells and other tumor cell lines we
found to exhibit PDGFR-dependent hypoxia-induced
macroautophagy (Supplemental Fig. 2K), the prosurvival
role of macroautophagy in response to hypoxic stress thus
may not be related to mitochondrial down-regulation but
to cytosolic protein degradation instead. Analysis of
canonical signaling pathways downstream from PDGFR
family members in BE cells demonstrated that these were
unperturbed by PDGFR-I, suggesting that PDGFR is
signaling to hypoxia-induced autophagy through a non-
canonical mechanism (Supplemental Fig. 2L).
Signaling responses to hypoxia fall into two main cat-
egories: HIF-dependent and HIF-independent (Pouyssegur
et al. 2006). HIF1a and HIF2a are transcription factor
subunits, the stability of which increase with lower
oxygen, allowing their accumulation and dimerization
with HIF1b/ARNT to form a functional transcription
factor (Pouyssegur et al. 2006). Reprogramming of cellular
metabolism by HIF1a up-regulated genes, such as the
increase in anaerobic glycolysis by glycolytic enzymes
and lactate dehydrogenase, is important for cellular
fitness under hypoxia (Pouyssegur et al. 2006). We ob-
served that HIF1a was stabilized specifically by hypoxia
in contrast to other macroautophagy-inducing stimuli
(Supplemetnal Fig. 3A). RNAi against ARNT resulted in
effective silencing (Fig. 3A) and inhibited hypoxia-
induced autophagosome accumulation (Fig. 3B). This
demonstrated a transcriptionally mediated macroauto-
phagic response to hypoxia. Further RNAi experiments
showed that macroautophagy required, specifically,
HIF1a activity (Fig. 3C,D). It is also evident that the
low levels of signaling through the hypoxia response
pathway under normoxia are sufficient to sponsor some
HIF1a accumulation (Supplemental Fig. 3A) and autoph-
agy induction (Supplemental Fig. 3B) in these cells,
consistent with the observation of a modest inhibition
of normoxic autophagy by inhibition of PDGFR family
members (Fig. 2A,D,E). BNIP3 and BNIP3L are HIF1a
target genes that have been shown to mediate macro-
autophagy under hypoxia in MEFs or during erythrocyte
maturation in vivo, respectively (Tracy et al. 2007;
Sandoval et al. 2008; Zhang et al. 2008). Where this
macroautophagy has been characterized, it has be shown
to be mitophagic in nature (Sandoval et al. 2008; Zhang
et al. 2008). BNIP3 and BNIP3L are regulated in response
to hypoxia-mediated HIF1a activation in BE cells; ARNT
siRNA transfection greatly reduced the expression levels
of both genes. However, direct BNIP3 and/or BNIP3L
silencing did not inhibit hypoxia-induced macroautoph-
agy (Fig. 3E,F). Taken together, these data suggest that the
hypoxia-mediated macroautophagy seen in tumor cells is
dependent on HIF1a activity. However, the PDGFR-
mediated hypoxic macroautophagy here is independent
of BNIP3 and BNIP3L function, consistent with the lack
of a mitophagic component to this autophagy.
We next wished to determine the point at which
PDGFR signaling converged with hypoxia signaling to
mediate macroautophagy. Gene expression profiling
revealed that PDGFR family inhibition affects HIF1a
activity, as read out in the transcriptional response to
hypoxia (Fig. 4A). Microarray analysis defined 281 signals
up-regulated by hypoxia. These signals were then com-
pared against those from hypoxic cells with either HIF1a
silencing or PDGFR-I treatment. On this basis, genes
were assigned as less up-regulated by hypoxia under these
inhibitory treatment conditions (Fig. 4A, green), further
up-regulated, or unaffected (Fig. 4A, red or black, re-
spectively; complete listing in Supplemental Fig. 4;
Supplemental Table 1). Most genes required HIF1a for
up-regulation, but only a proportion of these HIF1a
targets also required PDGFR family activity. Thus, HIF1a
target genes are divisible into two groups: a set requiring
Figure 3. Hypoxia-induced autophagy in tumor cells is mediated
via HIF1a/ARNT. (A,B) BE GFP-LC3 cells were transfected with
indicated siRNA oligonucleotides (nontargeting controls [NTCs] or
ARNT targeting), and at 48 h post-transfection were cultured in SFM
overnight and then exposed to hypoxia for 8 h before immunoblot
analysis (A) or scoring of the number of GFP-LC3 puncta-positive
cells (B) (n = 3 6 SEM; [*] P < 0.05 vs. each NTC). (C,D) BE GPP-LC3
cells were transfected with indicated siRNA oligonucleotides (non-
targeting controls [NTCs] or HIF1a or HIF2a targeting; HIF1/2a si1
is equimolar mix of HIF1a si2 and HIF2a si1 and HIF1/2a si2 is
equimolar mix of HIF1a si1 and HIF2a si2), and at 24 h post-
transfection were cultured in SFM overnight and exposed to hypoxia
for 8 h. Immunoblot analysis (C) or scoring of the number of GFP-
LC3 puncta-positive cells (D) (n = 3 6 SEM; [*] P < 0.05 vs. each
NTC; [**] P < 0.01; [#] not significant). (E,F) BE GFP-LC3 cells were
transfected with indicated siRNA oligonucleotides (nontargeting
controls [NTCs], BNIP3 targeting, BNIP3L targeting, or ARNT
targeting positive controls; BNIP3/3L si1 is equimolar mix of BNIP3
si1 and BNIP3L si2 and BNIP3/3L si2 is equimolar mix of BNIP3 si2
and BNIP3L si1), and at 48 h post-transfection were cultured in SFM
overnight and then exposed to hypoxia for 8 h before immunoblot
analysis (E, top) and quantitation of relative BNIP3L mRNA levels
by real-time PCR (E, bottom) or scoring of the number of GFP-LC3
puncta-positive cells (F) (n = 3 6 SEM; [*] P < 0.05 vs. each NTC;
[**]P < 0.01; [#] not significant).
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PDGFR family activity for up-regulation and within
which are those driving hypoxia-induced macroautoph-
agy (Group I, Fig. 4A), and a set not requiring PDGFR
family activity for up-regulation (Group II, Fig. 4A).
Quantitative RT–PCR (qRT–PCR) analysis of the tran-
script levels of genes from the microarray analysis con-
firmed this pattern of regulation (Fig. 4B,C). Genes
such as VEGFC, ITGB4, PDGFB, and PTPRB were up-
regulated by hypoxia, and up-regulation was abrogated
by HIF1a siRNA or PDGFR-I inhibitor (Fig. 4B). Genes
such as BNIP3L, BNIP3, HIG2, PFKFB4, and E2IG5 were
up-regulated by hypoxia, and up-regulation was abrogated
by HIF1a siRNA and only partially or insignificantly
affected by PDGFR-I treatment (Fig. 4C). Similar data
were obtained with PDGFR-II (Supplemental Fig. 5).
These data demonstrate that PDGFR signaling broad-
ens the HIF1a transcriptome and increases the scope
of the adaptive response to hypoxia. This broadened
transcriptional response has the capacity to promote
macroautophagy.
As the data indicated that autocrine PDGFR signaling
affects HIF1a function at some target promoters, we now
wished to determine the mechanism of this inhibition.
First, minimal hypoxia response element (HRE) reporter
assays using a sensitive HIF-binding site from phospho-
glycerate kinase (PGK), a Group I gene, revealed a de-
crease in hypoxic HIF-binding activity in the absence of
PDGFR signaling (Fig. 5A). This indicated that the
activity of the HIF1a transcriptional complex itself, in-
volved in activating the core elements of target pro-
moters, was perturbed. We decided to examine HIF1a
behavior more closely. At steady-state, post-hypoxic in-
duction of macroautophagy, we found an approximately
equal amount of HIF1a present in control cells and cells
treated with PDGFR inhibitor, and HIF1a was localized
to the nuclear compartment—to which shuttling is
Figure 4. PDGFR family signaling facilitates a subset of HIF1a
transcriptional responses. (A) Microarray analysis of BE GFP-LC3
cells exposed to hypoxia with or without inhibitory treatments
targeting PDGFR family kinase activity (PDGFR-I) or HIF1a protein
levels (HIF1a si). Cells were transfected with NTC1 or HIF1a si2 and
then switched to SFM overnight at 48 h post transfection. Sub-
sequent treatments were 8 h with DMSO (onto NTC1 or HIF1a
siRNA transfected cells) or PDGFR-I (5 mM) (onto NTC1 transfected
cells) under either normoxia (21% O2) or hypoxia (1% O2). RNAwas
then subjected to microarray analysis. Two-hundred-eighty-one gene
signals defined as being up-regulated in hypoxic vehicle condition
relative to normoxia vehicle condition were analyzed for differences
between hypoxia vehicle condition and hypoxia with additional
inhibitory treatments (PDFGR-I treatment or HIF1a RNAi). Green
signals indicate genes less up-regulated by hypoxia when inhibitory
treatment is applied. Red signals indicate genes more up-regulated,
and black indicates those with no significant difference. Group I
consists of genes whose hypoxic increase in expression is reduced by
PDGFR-I treatment or HIF1a siRNA. Group II consists of genes
whose hypoxic increase in expression is sensitive to HIF1a siRNA
but not PDGFR-I treatment. Examples of genes in each group are
given in boxes alongside (for a comprehensive list, see Supplemental
Fig. 4; Supplemental Table 1). (B) RNA used for microarray analysis
in A, which was subjected to real-time PCR quantification of four
Group I genes (n = 3 6 SD). (C) RNA used for microarray analysis in
A, which was subjected to real-time PCR quantification of five
Group II genes (n = 3 6 SD). (B,C) (*) P < 0.05; (*) P < 0.01;(***) P <
0.005; (#)not significant, vs. hypoxia alone. Figure 5. PDGFR family signaling regulates the kinetics of HIF1a
protein turnover. (A) BE GFP-LC3 and A431 GFP-LC3 cells were
assayed for HIF-dependent transcription by transfection of wild-type
PGK HRE (wHRE) and mutant HRE reporter (mHRE) constructs as
described in the Materials and Methods, and then overnight culture
in SFM with DMSO vehicle or PDGFR-I (5 mM) followed by
luciferase assay. Graph shows fold increase in wHRE/mHRE signal
in hypoxic cultures (n = 3 6 SD; [***] P < 0.005 vs. DMSO). (B)
Confluent BE GFP-LC3 cells were cultured in SFM under hypoxic
conditions for 8 h with DMSO, PDGFR-I (5 mM), or PDGFR-II (20
mM); fractionated into cytosolic (Cyt) or nuclear (Nuc) fractions; and
probed for indicated proteins. Confluent BE GFP-LC3 cells were
cultured in SFM under hypoxic conditions for 8 h, with DMSO or
PDGFR-I (5 mM) (C,D) and in the presence or absence of MG132 (20
mM) (D). Cells were lysed at 1 h, 2 h, 3 h, 4 h, and 6 h (C) or 2 h (D)
and probed for indicated proteins. (E) Confluent BE GFP-LC3 cells
were cultured in SFM under hypoxic conditions for 8 h with DMSO
or PDGFR-I (5 mM). Then (t = 0), a sample was lysed and cyclohex-
imide (100 mgmL1) was added to cultures, with lysis of cells
performed every subsequent 20 min. Lysates were immunoblotted
for HIF1a as shown in representative figure (E), and half-lives of
HIF1a protein were calculated after quantification (F) (n = 3 6 SEM;
[*] P < 0.05). (G) Confluent BE GFP-LC3 cells were cultured in SFM
under normoxic or hypoxic conditions for 8 h with DMSO or
PDGFR-I (5 mM), and RNA was extracted and subjected to real-time
PCR quantification of HIF1a mRNA (n = 3 6 SD; [**] P < 0.01 vs.
DMSO).
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required to effect transactivation—in both instances (Fig.
5B). However, a time course of the events immediately
following exposure of cells to hypoxia demonstrated that
cells with inhibited PDGFR signaling exhibit a retarded
accumulation of HIF1a protein only at early time points
(Fig. 5C) due to enhanced proteasomal degradation, as
shown by treatment with MG-132 proteasome inhibitor
(Fig. 5D). However, even after several hours, when steady-
state levels of HIF1a protein in cells lacking PDGFR
signaling have recovered to those seen in uncompromised
cells, the degradation rate of HIF1a is still markedly
enhanced, as demonstrated by cycloheximide chase
experiments (Fig. 5E,F). However, the steady-state levels
of HIF1a are buffered by a compensatory increase in
HIF1a mRNA in the absence of PDGFR signaling, due
to the abrogation of a negative feedback loop that oper-
ates to repress HIF1a mRNA under control hypoxic
conditions (Fig. 5G). Taken together, these data suggest
that a more dynamic and transient pool of HIF1a protein
in the absence of PDGFR signaling, being turned over
faster due to balanced increases in both synthesis and
degradation, has less capacity to promote transcription
from HRE-containing target genes (for model, see Sup-
plemental Fig. 6).
Macroautophagy is regulated downstream from diverse
stress signals through different signaling pathways. Here
we demonstrated PDGFR-mediated regulation of a hyp-
oxia HIF1a-driven mechanism for induction of macro-
autophagy. It is worth noting, however, that in extreme
situations, such as anoxia (<0.01% O2), HIF-independent,
and presumably PDGFR-independent, mechanisms have
been suggested to play a dominant role in regulating
macroautophagy (Papandreou et al. 2008). Interestingly, it
has been shown previously that IL-3 promotes nutrient
uptake, presumably by binding to its cognate growth
factor receptor, and deprivation of this signal causes
a starvation response and induction of autophagic sur-
vival (Lum et al. 2005). Here we described a different
paradigm for growth factor receptor signaling in the
regulation of macroautophagy, where signaling facilitates
themaximum cellular response to a cellular stress, in this
instance hypoxia. We propose that autocrine PDGFR
signaling allows tumor cells to autonomously maintain
a level of HIF1a activity at a given oxygen tension and
HIF1a protein level that is greater than it would be
without this signaling. This is attained by increasing
the half-life of HIF1a, which is prevented from causing
runaway accumulation of HIF1a protein by negative
feedback on HIF1a message levels. The consequence of
the presence of this less dynamic and transient pool of
HIF1a protein is to increase the number of phenotypic
changes promoted by HIF1a at a given oxygen tension,
and thus the number of strategies available to the tumor
cell to adapt to low oxygen and the consequent metabolic
stress. One such change is the induction of macroautoph-
agy involving cytosolic protein and p62 degradation un-
der hypoxia, distinct from the mitophagy seen in MEFs
that acts to down-regulate oxidative phosphorylation
(Zhang et al. 2008). Macroautophagy maintains cell
viability in the face of metabolic stress. The autocrine
signaling of PDGFR thus gives an obvious advantage to
tumor cells by enabling survival in a hypoxic microenvi-
ronment during tumorigenesis.
In conclusion, identifying signaling mechanisms by
which tumor cells promote macroautophagic responses
to metabolic stresses, such as PDGFR signaling in re-
sponse to hypoxia, will provide new targets for selective
therapeutic targeting of tumor cell viability.
Materials and methods
Cell lines and reagents
BE, A431, and HCT116 cells expressing ecotropic retrovirus receptor (a
gift fromDan Croft) stably infected with pBabe-Puro EGFP-LC3 retrovirus
(‘‘GFP-LC3’’ lines), and primary MEF cells were cultured in DMEM
(Gibco) supplemented with 10% FBS (Hyclone).Drosophila melanogaster
S2R+ GFP-LC3 cells were derived from S2R+ cells stably transfected with
pAc5.1 (Invitrogen) engineered to express EGFP-Drosophila Atg8a and
cultured at room temperature and atmospheric oxygen in Schneider’s
Drosophilamedium. All mammalian cell lines were cultured in 21% O2/
5% CO2 or, in the case of diminished O2, in an InVivo 500 hypoxia
workstation at 5% CO2. MG132, E64d, pepstatin A, PDGFR-I (alias PDGF
Receptor Tyrosine Kinase Inhibitor III), and PDGFR-II (alias PDGF Re-
ceptor Tyrosine Kinase Inhibitor I) inhibitors were obtained from Calbio-
chem. Bafilomycin and cycloheximide were from Sigma. Recombinant
PDGF-AB was from R&D Systems, and recombinant FMS was from Cell
Signaling Technology (CSF1R [K539-C972]). ELISAs were performed with
Quantikine immunoassay kits for human PDGF-AB and M-CSF from
R&D Systems.
Microscopy
GFP-LC3 cells were grown on glass and fixed in 4% paraformaldehyde
before mounting using DAKO mountant (DAKO Cytomation). Confocal
images were obtained as Z-stacks using a Leica SP2 confocal. Cells were
scored blindly for presence of GFP-LC3 puncta in multiple epifluores-
cence images (>10 per condition, >200 cells) obtained using a 1003
objective lens on an Axioskop 50 microscope (Zeiss). Automatic exposure
times minimized differences in brightness between images due to
heterogeneous expression among cells.
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